All lobbying filings

ARENTFOX SCHIFF LLP

ARENTFOX SCHIFF LLP filed a Q3 report for ORGANOGENESIS INC. on October 19, 2026, reporting $40,000 in lobbying income.

Lobbying for ORGANOGENESIS INC. · Biotech company

All filings by ARENTFOX SCHIFF LLP · Everything ORGANOGENESIS INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$40,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Food and Drug Administration policy on chronic wound healing products

Medicare/Medicaid

Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations and Discarded Products policy Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027)

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.